Redsense Medical AB (publ) (XSAT:REDS)

Redsense Medical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	65	117	107	133	345	628
Market Cap Growth	-46.75%	9.42%	-19.83%	-61.46%	-44.97%	270.87%
Enterprise Value	52	101	100	119	319	623
Last Close Price	3.93	7.10	7.60	9.48	24.60	36.88
PE Ratio	223.24	341.40	-	-	-	-
PS Ratio	2.03	4.06	4.18	7.95	21.13	36.70
PB Ratio	1.80	2.95	4.62	4.90	9.21	8.57
P/TBV Ratio	1.80	2.95	4.62	4.90	9.21	8.57
EV/Sales Ratio	1.65	3.50	3.91	7.10	19.50	36.43
EV/EBITDA Ratio	29.92	366.15	-	-	-	-
EV/EBIT Ratio	35.83	481.77	-	-	-	-
Debt / Equity Ratio	-	-	-	-	0.07	-
Asset Turnover	0.80	0.84	0.89	0.45	0.27	0.35
Inventory Turnover	2.15	2.91	8.57	3.78	3.20	4.79
Quick Ratio	4.57	9.89	3.43	4.42	9.78	12.35
Current Ratio	6.45	12.66	3.88	5.03	10.34	12.85
Return on Equity (ROE)	0.85%	1.09%	-17.96%	-27.10%	-14.40%	-20.50%
Return on Assets (ROA)	2.29%	0.38%	-11.00%	-17.25%	-12.29%	-10.39%
Return on Capital Employed (ROCE)	4.10%	0.50%	-21.80%	-37.60%	-29.90%	-11.10%
Earnings Yield	0.47%	0.29%	-4.23%	-6.58%	-2.31%	-1.44%
FCF Yield	-4.48%	-7.06%	-4.78%	-7.39%	-3.64%	-1.06%
Dividend Yield	-	-	-	-	-	5.80%
Buyback Yield / Dilution	-267.27%	-21.25%	0.16%	-0.60%	-	-15.33%
Total Shareholder Return	-267.27%	-21.25%	0.16%	-0.60%	-	-9.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.